These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8281514)

  • 1. A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings, and tumors.
    Meloni AM; Peier AM; Haddad FS; Powell IJ; Block AW; Huben RP; Todd I; Potter W; Sandberg AA
    Cancer Genet Cytogenet; 1993 Dec; 71(2):105-18. PubMed ID: 8281514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interphase cytogenetic diagnosis of bladder cancer on cells from urine and bladder washing.
    Junker K; Werner W; Mueller C; Ebert W; Schubert J; Claussen U
    Int J Oncol; 1999 Feb; 14(2):309-13. PubMed ID: 9917507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
    Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
    J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer.
    Sarosdy MF; Schellhammer P; Bokinsky G; Kahn P; Chao R; Yore L; Zadra J; Burzon D; Osher G; Bridge JA; Anderson S; Johansson SL; Lieber M; Soloway M; Flom K
    J Urol; 2002 Nov; 168(5):1950-4. PubMed ID: 12394683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
    Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive detection and prediction of bladder cancer by fluorescence in situ hybridization analysis of exfoliated urothelial cells in voided urine.
    Ishiwata S; Takahashi S; Homma Y; Tanaka Y; Kameyama S; Hosaka Y; Kitamura T
    Urology; 2001 Apr; 57(4):811-5. PubMed ID: 11306420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.
    Gilbert SM; Veltri RW; Sawczuk A; Shabsigh A; Knowles DR; Bright S; O'Dowd GJ; Olsson CA; Benson MC; Sawczuk IS
    Urology; 2003 Mar; 61(3):539-43. PubMed ID: 12639642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis.
    Curigliano G; Ferretti G; Flamini G; Goldhirsch A; de Braud F; Calabro MG; Mandaly M; Nole F; De Pas T; D'Addessi A; Cittadini A
    Anticancer Res; 2001; 21(4B):3015-20. PubMed ID: 11712804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].
    Shou J; Wang M; Ma J
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology.
    Huang WT; Li LY; Pang J; Ruan XX; Sun QP; Yang WJ; Gao X
    Neoplasma; 2012; 59(4):355-60. PubMed ID: 22489689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Numeric aberrations of HER-2 and chromosome 17 detected by fluorescence in situ hybridization in urine-exfoliated cells from patients with urothelial carcinoma.
    Inoue T; Sato K; Tsuchiya N; Matsuura S; Iinuma M; Habuchi T; Kato T
    Urology; 2004 Sep; 64(3):617-21. PubMed ID: 15351620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative evaluation of the predictive value of UroVysion and AURKA FISH tests of urine sediment cells for the diagnosis of bladder cancer].
    Vorobtsova IE; Kouzova ED; Kolesnikova IS
    Vopr Onkol; 2013; 59(4):483-6. PubMed ID: 24032224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
    Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
    Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cytogenetic analysis of urothelial carcinomas using urine samples.
    Ayati M; Tousi VN; Sabokba T; Vaziri-Nasab H; Mehrkhani F; Jamshidian H; Dastan J; Mosavi-Jarrahi AR; Ghaffari SR
    Asian Pac J Cancer Prev; 2008; 9(4):687-90. PubMed ID: 19256760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FISH and genetics advance bladder-cancer diagnosis.
    Hollenberg G
    MLO Med Lab Obs; 2004 Jun; 36(6):26-7. PubMed ID: 15242179
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluorescent in situ hybridization as a predictor of relapse in urothelial carcinoma.
    García-Peláez B; Trias I; Román R; Pubill C; Banús JM; Puig X
    Actas Urol Esp; 2013; 37(7):395-400. PubMed ID: 23453297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of DNA flow cytometry and cytology of bladder washings: review of discordant cases.
    Bakhos R; Shankey TV; Flanigan RC; Fisher S; Wojcik EM
    Diagn Cytopathol; 2000 Feb; 22(2):65-9. PubMed ID: 10649514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive molecular detection of bladder cancer recurrence.
    Amira N; Mourah S; Rozet F; Teillac P; Fiet J; Aubin P; Cortesse A; Desgrandchamps F; Le Duc A; Cussenot O; Soliman H
    Int J Cancer; 2002 Sep; 101(3):293-7. PubMed ID: 12209982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cytogenetic characterization and diagnostics of bladder cancer.
    Houskova L; Zemanova Z; Babjuk M; Melichercikova J; Pesl M; Michalova K
    Neoplasma; 2007; 54(6):511-6. PubMed ID: 17949235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.